Accumulating evidence underscores the significant impact of the Triggering receptor expressed on myeloid cells-2 (TREM2)-activating protein of 12kDa (DAP12) system in central nervous system CNS disorders such as neurodegenerative diseases and stroke (136). This evidence concerns the gene TREM2 and neurodegenerative disease.